Response to Office Action

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1957 (Rev 10/2011)

OMB No. 0651-0050 (Exp 09/20/2020)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1957 (Rev 10/2011)

OMB No. 0651-0050 (Exp 09/20/2020)

Response to Office Action

To the Commissioner for Trademarks:

Application serial no. 87843152 ELZONRIS(Standard Characters, see http://uspto.report/TM/87843152/mark.png) has been amended as follows:

CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 005 for pharmaceutical and biotechnological preparations, drugs, and diagnostic reagents for the diagnosis and treatment of cancer, auto-immune diseases and other diseases
Original Filing Basis:
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

Proposed:
Tracked Text Description: pharmaceutical and biotechnological preparations, drugs, and diagnostic reagents for the diagnosis and treatment of cancer, auto-immune diseases and other diseases; pharmaceutical preparations for the diagnosis and treatment of cancer and auto-immune diseases; drug delivery agent in the form of infusion for the diagnosis and treatment of cancer and auto-immune diseases; diagnostic reagents for medicinal use, namely, for the diagnosis and treatment of cancer and auto-immune diseasesClass 005 for pharmaceutical preparations for the diagnosis and treatment of cancer and auto-immune diseases; drug delivery agent in the form of infusion for the diagnosis and treatment of cancer and auto-immune diseases; diagnostic reagents for medicinal use, namely, for the diagnosis and treatment of cancer and auto-immune diseases
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

ADDITIONAL STATEMENTS
Translation
The wording ELZONRIS has no meaning in a foreign language.


SIGNATURE(S)
Response Signature
Signature: /Jessica S. Parise/     Date: 12/12/2018
Signatory's Name: Jessica S. Parise
Signatory's Position: Attorney of Record, NY Bar Member

Signatory's Phone Number: 212 813 8800

The signatory has confirmed that he/she is an attorney who is a member in good standing of the bar of the highest court of a U.S. state, which includes the District of Columbia, Puerto Rico, and other federal territories and possessions; and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S. attorney or a Canadian attorney/agent not currently associated with his/her company/firm previously represented the owner/holder in this matter: (1) the owner/holder has filed or is concurrently filing a signed revocation of or substitute power of attorney with the USPTO; (2) the USPTO has granted the request of the prior representative to withdraw; (3) the owner/holder has filed a power of attorney appointing him/her in this matter; or (4) the owner's/holder's appointed U.S. attorney or Canadian attorney/agent has filed a power of attorney appointing him/her as an associate attorney in this matter.

        
Serial Number: 87843152
Internet Transmission Date: Wed Dec 12 13:37:06 EST 2018
TEAS Stamp: USPTO/ROA-XX.XXX.XX.XX-20181212133706447
926-87843152-610c17d856ba5c26d42baf81059
cbc0449fbf9947266633de255c59fa9364647b-N
/A-N/A-20181212133149554010